268 related articles for article (PubMed ID: 32683496)
1. Familial aggregation of longevity in giant cell arteritis and polymyalgia rheumatica.
Milchert M; Brzosko M
Rheumatol Int; 2020 Dec; 40(12):2071-2075. PubMed ID: 32683496
[TBL] [Abstract][Full Text] [Related]
2. Familial aggregation in giant cell arteritis and polymyalgia rheumatica: a comprehensive literature review including 4 new families.
Liozon E; Ouattara B; Rhaiem K; Ly K; Bezanahary H; Loustaud V; Letellier P; Drouet M; Vidal E
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S89-94. PubMed ID: 19646354
[TBL] [Abstract][Full Text] [Related]
3. Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review.
Liozon E; Parreau S; Filloux M; Dumonteil S; Gondran G; Bezanahary H; Ly KH; Fauchais AL
Autoimmun Rev; 2021 Feb; 20(2):102732. PubMed ID: 33326851
[TBL] [Abstract][Full Text] [Related]
4. Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases.
Pujades-Rodriguez M; Duyx B; Thomas SL; Stogiannis D; Smeeth L; Hemingway H
Heart; 2016 Mar; 102(5):383-9. PubMed ID: 26786818
[TBL] [Abstract][Full Text] [Related]
5. Familial aggregation of polymyalgia rheumatica and giant cell arteritis: genetic and T cell repertoire analysis.
Bartolome MJ; Martínez-Taboda VM; Lopez-Hoyos M; Blanco R; Rodriguez-Valverde V
Clin Exp Rheumatol; 2001; 19(3):259-64. PubMed ID: 11407077
[TBL] [Abstract][Full Text] [Related]
6. HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: influence on clinical subgroups and prognosis.
Martínez-Taboda VM; Bartolome MJ; Lopez-Hoyos M; Blanco R; Mata C; Calvo J; Corrales A; Rodriguez-Valverde V
Semin Arthritis Rheum; 2004 Aug; 34(1):454-64. PubMed ID: 15305244
[TBL] [Abstract][Full Text] [Related]
7. Familial giant cell arteritis and polymyalgia rheumatica: aggregation in 2 families.
Fietta P; Manganelli P; Zanetti A; Neri TM
J Rheumatol; 2002 Jul; 29(7):1551-5. PubMed ID: 12136919
[TBL] [Abstract][Full Text] [Related]
8. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity.
Salvarani C; Casali B; Boiardi L; Ranzi A; Macchioni P; Nicoli D; Farnetti E; Brini M; Portioli I
J Rheumatol; 2000 May; 27(5):1215-21. PubMed ID: 10813290
[TBL] [Abstract][Full Text] [Related]
9. Distribution of HLA-DRB1 alleles of patients with polymyalgia rheumatica and giant cell arteritis in a Mediterranean population.
Combe B; Sany J; Le Quellec A; Clot J; Eliaou JF
J Rheumatol; 1998 Jan; 25(1):94-8. PubMed ID: 9458210
[TBL] [Abstract][Full Text] [Related]
10. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms.
Mattey DL; Hajeer AH; Dababneh A; Thomson W; González-Gay MA; García-Porrúa C; Ollier WE
Arthritis Rheum; 2000 Aug; 43(8):1749-55. PubMed ID: 10943865
[TBL] [Abstract][Full Text] [Related]
11. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy.
Salvarani C; Macchioni P; Zizzi F; Mantovani W; Rossi F; Castri C; Capozzoli N; Baricchi R; Boiardi L; Chiaravalloti F
Arthritis Rheum; 1991 Mar; 34(3):351-6. PubMed ID: 2003856
[TBL] [Abstract][Full Text] [Related]
12. IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis.
Gonzalez-Gay MA; Hajeer AH; Dababneh A; Garcia-Porrua C; Mattey DL; Amoli MM; Thomson W; Ollier WE
Clin Exp Rheumatol; 2002; 20(2):179-84. PubMed ID: 12051396
[TBL] [Abstract][Full Text] [Related]
13. Familial association of giant cell arteritis. A case report and brief review.
Granato JE; Abben RP; May WS
Arch Intern Med; 1981 Jan; 141(1):115-7. PubMed ID: 7447573
[TBL] [Abstract][Full Text] [Related]
14. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis.
Weyand CM; Hunder NN; Hicok KC; Hunder GG; Goronzy JJ
Arthritis Rheum; 1994 Apr; 37(4):514-20. PubMed ID: 8147928
[TBL] [Abstract][Full Text] [Related]
15. Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.
Liozon E; de Boysson H; Dalmay F; Gondran G; Bezanahary H; Fauchais AL; Ly KH
J Rheumatol; 2018 May; 45(5):678-685. PubMed ID: 29545449
[TBL] [Abstract][Full Text] [Related]
16. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.
van Sleen Y; Graver JC; Abdulahad WH; van der Geest KSM; Boots AMH; Sandovici M; Brouwer E
Front Immunol; 2019; 10():1981. PubMed ID: 31507597
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study.
Vieira M; Comarmond C; Labreuche J; Mirouse A; Saadoun D; Richez C; Flipo RM; Hachulla E; Drumez E; Cacoub P;
J Autoimmun; 2022 Oct; 132():102868. PubMed ID: 35926375
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin releasing hormone promoter polymorphisms in giant cell arteritis and polymyalgia rheumatica.
Gonzalez-Gay MA; Hajeer AH; Dababneh A; Garcia-Porrua C; Amoli MM; Thomson W; Ollier WE
Clin Exp Rheumatol; 2002; 20(2):133-8. PubMed ID: 12051390
[TBL] [Abstract][Full Text] [Related]
20. Risk of venous and arterial thromboembolism in patients with giant cell arteritis and/or polymyalgia rheumatica: A Veterans Health Administration population-based study in the United States.
Michailidou D; Zhang T; Stamatis P; Ng B
J Intern Med; 2022 May; 291(5):665-675. PubMed ID: 34982490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
